![BMJ on Twitter: "Anticancer chemotherapy in teenagers & young adults: managing long term side effects https://t.co/5msrPtxVWB https://t.co/H3eBnUFOzJ" / Twitter BMJ on Twitter: "Anticancer chemotherapy in teenagers & young adults: managing long term side effects https://t.co/5msrPtxVWB https://t.co/H3eBnUFOzJ" / Twitter](https://pbs.twimg.com/media/Cr1QOqjWEAAOKXN.jpg)
BMJ on Twitter: "Anticancer chemotherapy in teenagers & young adults: managing long term side effects https://t.co/5msrPtxVWB https://t.co/H3eBnUFOzJ" / Twitter
![Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis - ScienceDirect Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0147651320317255-ga1.jpg)
Cyclophosphamide induced physiological and biochemical changes in mice with an emphasis on sensitivity analysis - ScienceDirect
![Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases Subramanian R, Pathak H, Ravindran V - Indian J Rheumatol Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases Subramanian R, Pathak H, Ravindran V - Indian J Rheumatol](https://www.indianjrheumatol.com/articles/2019/14/2/images/IndianJRheumatol_2019_14_2_127_257843_t3.jpg)
Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases Subramanian R, Pathak H, Ravindran V - Indian J Rheumatol
![Chemotherapy and Biotherapy Agents. Objectives At the completion of this session the participant will be able to: ◦ Identify common side effects for individual. - ppt download Chemotherapy and Biotherapy Agents. Objectives At the completion of this session the participant will be able to: ◦ Identify common side effects for individual. - ppt download](https://images.slideplayer.com/16/4882231/slides/slide_4.jpg)
Chemotherapy and Biotherapy Agents. Objectives At the completion of this session the participant will be able to: ◦ Identify common side effects for individual. - ppt download
![Is there still a role for cyclophosphamide in the treatment of systemic sclerosis? - Madelon C Vonk, 2021 Is there still a role for cyclophosphamide in the treatment of systemic sclerosis? - Madelon C Vonk, 2021](https://journals.sagepub.com/cms/10.1177/2397198320961673/asset/images/large/10.1177_2397198320961673-fig1.jpeg)
Is there still a role for cyclophosphamide in the treatment of systemic sclerosis? - Madelon C Vonk, 2021
![Arvind Canchi (Conjeevaram)🇮🇳 on Twitter: "Ponticelli on prevention of # cyclophosphamide drug toxicity. #ERAEDTA18 https://t.co/bVxCsxdSCl" / Twitter Arvind Canchi (Conjeevaram)🇮🇳 on Twitter: "Ponticelli on prevention of # cyclophosphamide drug toxicity. #ERAEDTA18 https://t.co/bVxCsxdSCl" / Twitter](https://pbs.twimg.com/media/Dd8lL_EVMAEFBVO.jpg:large)
Arvind Canchi (Conjeevaram)🇮🇳 on Twitter: "Ponticelli on prevention of # cyclophosphamide drug toxicity. #ERAEDTA18 https://t.co/bVxCsxdSCl" / Twitter
Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment
![Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial - The Lancet Respiratory Medicine Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/f9925654-2075-4af3-810f-b1d854511658/gr1_lrg.jpg)
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial - The Lancet Respiratory Medicine
![Frontiers | Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification and Maternal Factors' Transcription During Oocyte Growth Frontiers | Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification and Maternal Factors' Transcription During Oocyte Growth](https://www.frontiersin.org/files/Articles/682060/fcell-09-682060-HTML/image_m/fcell-09-682060-g001.jpg)
Frontiers | Cyclophosphamide Exposure Causes Long-Term Detrimental Effect of Oocytes Developmental Competence Through Affecting the Epigenetic Modification and Maternal Factors' Transcription During Oocyte Growth
![Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial - The Lancet Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial - The Lancet](https://www.thelancet.com/cms/attachment/2001011662/2003799460/gr1.gif)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial - The Lancet
![Paradoxical risk of reduced fertility after exposure of prepubertal mice to vincristine or cyclophosphamide at low gonadotoxic doses in humans | Scientific Reports Paradoxical risk of reduced fertility after exposure of prepubertal mice to vincristine or cyclophosphamide at low gonadotoxic doses in humans | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-74862-8/MediaObjects/41598_2020_74862_Fig1_HTML.png)